相似文献
1
A Mass Redistribution Algorithm for Right Censored and Left Truncated Time to Event Data.
J Stat Plan Inference. 2009 Sep 1;139(9):3329-3339. doi: 10.1016/j.jspi.2009.03.007.
2
A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
Stat Med. 2011 Jul 20;30(16):1933-51. doi: 10.1002/sim.4264. Epub 2011 May 9.
3
A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data.
Biom J. 2010 Feb;52(1):126-37. doi: 10.1002/bimj.200900039.
4
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.
Trials. 2021 Jun 29;22(1):420. doi: 10.1186/s13063-021-05354-x.
5
Estimating cumulative incidence functions in competing risks data with dependent left-truncation.
Stat Med. 2020 Feb 20;39(4):481-493. doi: 10.1002/sim.8421. Epub 2019 Dec 1.
6
Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
Biometrics. 2011 Mar;67(1):39-49. doi: 10.1111/j.1541-0420.2010.01420.x.
7
On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.
Lifetime Data Anal. 2024 Jul;30(3):649-666. doi: 10.1007/s10985-024-09623-0. Epub 2024 Mar 21.
8
Hidden Imputations and the Kaplan-Meier Estimator.
Am J Epidemiol. 2020 Nov 2;189(11):1408-1411. doi: 10.1093/aje/kwaa086.
9
The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.
Am Stat. 2001;55(3):207-210. doi: 10.1198/000313001317098185. Epub 2012 Jan 1.
10
A kernel nonparametric quantile estimator for right-censored competing risks data.
J Appl Stat. 2019 Jun 19;47(1):61-75. doi: 10.1080/02664763.2019.1631267. eCollection 2020.
引用本文的文献
1
General regression model for the subdistribution of a competing risk under left-truncation and right-censoring.
Biometrika. 2020 Jun 17;107(4):949-964. doi: 10.1093/biomet/asaa034. eCollection 2020 Dec.
2
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Front Pharmacol. 2019 Jan 29;9:1567. doi: 10.3389/fphar.2018.01567. eCollection 2018.
3
How to handle mortality when investigating length of hospital stay and time to clinical stability.
BMC Med Res Methodol. 2011 Oct 26;11:144. doi: 10.1186/1471-2288-11-144.
4
A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
Stat Med. 2011 Jul 20;30(16):1933-51. doi: 10.1002/sim.4264. Epub 2011 May 9.
本文引用的文献
1
Nonparametric maximum likelihood estimation for competing risks survival data subject to interval censoring and truncation.
Biometrics. 2001 Mar;57(1):74-80. doi: 10.1111/j.0006-341x.2001.00074.x.
2
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.
Stat Med. 1999 Mar 30;18(6):695-706. doi: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o.
3
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
N Engl J Med. 1994 Nov 10;331(19):1253-8. doi: 10.1056/NEJM199411103311902.
Zotero 插件